Market Cap 124.32M
Revenue (ttm) 0.00
Net Income (ttm) -69.68M
EPS (ttm) N/A
PE Ratio 4.34
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 725,800
Avg Vol 756,050
Day's Range N/A - N/A
Shares Out 57.29M
Stochastic %K 21%
Beta 3.34
Analysts Strong Sell
Price Target $9.57

Company Profile

Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in Phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as Phase 1 clinical trial to treat glioblastoma. It is also develo...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 252 0848
Address:
One Main Street, 14th Floor, Cambridge, United States
Invest2live
Invest2live Mar. 18 at 8:22 PM
$ASRT 36% already; congrats. This has long way to go. Alerted several times. Congratulations 🎈 🎉🎊 Checkout $AKBA and $BDTX
0 · Reply
isaacsebring
isaacsebring Mar. 17 at 5:09 PM
$BDTX Love how any catalyst can make this one pop. Can’t wait for big news!
0 · Reply
Marklacey123
Marklacey123 Mar. 17 at 4:26 PM
$BDTX JEFFERIES REIT BUY PT $10, RAYMOND JAMES REIT BUY PT $11, STEIFEL REIT BUY PT $8
0 · Reply
erevnon
erevnon Mar. 17 at 2:37 PM
Wedbush maintains Black Diamond Therapeutic $BDTX at Outperform and raises the price target from $13 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Marklacey123
Marklacey123 Mar. 17 at 1:45 PM
$BDTX Wedbush Maintains Outperform on Black Diamond Therapeutic, Raises Price Target to $14
0 · Reply
Stock_Squatch_Watcher
Stock_Squatch_Watcher Mar. 16 at 10:40 PM
$BDTX So earnings were in fact, today. 🙄🤷‍♂️ Great cash position, although once they begin the brain 🧠 trial it will require some $$, but should not have any dilution concerns for a year at least. The next 3 months are key with top line data coming and a partnership expected, otherwise why say new lung trial will begin in 2Q. I’m holding tight, not much risk if you are in at this pps range ($1.95-$2.25). ✌️🍀🦶🏿
2 · Reply
isaacsebring
isaacsebring Mar. 16 at 2:16 AM
$BDTX hold this one gentleman! Been looking at forums in regards to the trial, and a lot of positive results! It’s a win for patients and investors. I like companies like this…
1 · Reply
Ramanda87
Ramanda87 Mar. 12 at 3:54 PM
$BDTX I’m nearing the point where I’m going to reallocate my monies else where. You guys think this is moving soon?
2 · Reply
Stock_Squatch_Watcher
Stock_Squatch_Watcher Mar. 10 at 4:26 PM
$BDTX Hoping for (expecting) some solid update on the brain study and tangible news regarding lung study partner not just ”we are in discussions jargon” during earnings call. 🤞🍀🦶🏿
1 · Reply
fatpie68
fatpie68 Mar. 10 at 1:26 PM
I thought $BDTX was to release its ER before market today? What's up?
2 · Reply
Latest News on BDTX
Black Diamond Therapeutics: In Decline, But Why?

Mar 13, 2025, 3:47 PM EDT - 1 year ago

Black Diamond Therapeutics: In Decline, But Why?


Black Diamond's BDTX-1535: A Brainy Bet In Cancer Therapy

Oct 12, 2023, 8:31 AM EDT - 2 years ago

Black Diamond's BDTX-1535: A Brainy Bet In Cancer Therapy


Black Diamond Therapeutics Announces CEO Transition

Sep 18, 2023, 7:00 AM EDT - 2 years ago

Black Diamond Therapeutics Announces CEO Transition


Invest2live
Invest2live Mar. 18 at 8:22 PM
$ASRT 36% already; congrats. This has long way to go. Alerted several times. Congratulations 🎈 🎉🎊 Checkout $AKBA and $BDTX
0 · Reply
isaacsebring
isaacsebring Mar. 17 at 5:09 PM
$BDTX Love how any catalyst can make this one pop. Can’t wait for big news!
0 · Reply
Marklacey123
Marklacey123 Mar. 17 at 4:26 PM
$BDTX JEFFERIES REIT BUY PT $10, RAYMOND JAMES REIT BUY PT $11, STEIFEL REIT BUY PT $8
0 · Reply
erevnon
erevnon Mar. 17 at 2:37 PM
Wedbush maintains Black Diamond Therapeutic $BDTX at Outperform and raises the price target from $13 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Marklacey123
Marklacey123 Mar. 17 at 1:45 PM
$BDTX Wedbush Maintains Outperform on Black Diamond Therapeutic, Raises Price Target to $14
0 · Reply
Stock_Squatch_Watcher
Stock_Squatch_Watcher Mar. 16 at 10:40 PM
$BDTX So earnings were in fact, today. 🙄🤷‍♂️ Great cash position, although once they begin the brain 🧠 trial it will require some $$, but should not have any dilution concerns for a year at least. The next 3 months are key with top line data coming and a partnership expected, otherwise why say new lung trial will begin in 2Q. I’m holding tight, not much risk if you are in at this pps range ($1.95-$2.25). ✌️🍀🦶🏿
2 · Reply
isaacsebring
isaacsebring Mar. 16 at 2:16 AM
$BDTX hold this one gentleman! Been looking at forums in regards to the trial, and a lot of positive results! It’s a win for patients and investors. I like companies like this…
1 · Reply
Ramanda87
Ramanda87 Mar. 12 at 3:54 PM
$BDTX I’m nearing the point where I’m going to reallocate my monies else where. You guys think this is moving soon?
2 · Reply
Stock_Squatch_Watcher
Stock_Squatch_Watcher Mar. 10 at 4:26 PM
$BDTX Hoping for (expecting) some solid update on the brain study and tangible news regarding lung study partner not just ”we are in discussions jargon” during earnings call. 🤞🍀🦶🏿
1 · Reply
fatpie68
fatpie68 Mar. 10 at 1:26 PM
I thought $BDTX was to release its ER before market today? What's up?
2 · Reply
Stock_Squatch_Watcher
Stock_Squatch_Watcher Mar. 6 at 4:40 PM
$BDTX P2 lung was solid and they saw positive brain cancer activity that was much better then they hypothesized, without having to do an initial P1 study to prove it. So they end up with 2 shots on goal coming out of the lung P2. Do your own DD, IMO, anything below $2.00 on this pps is a crazy good low risk play on a moderate risk drug like 1535. ✌️🦶🏿
2 · Reply
xxxxxxx01
xxxxxxx01 Mar. 6 at 12:55 PM
$BATL $BDTX $INDO SYBAU SAVE THE WORLD FROM AMERICA AND ISRAEL MORE LIKE
0 · Reply
Puke_Duke
Puke_Duke Mar. 5 at 11:48 PM
$INDO $BATL $BDTX A penny for your thought's? "Iran has been a terrorist threat to the United States and Israel since the 1979 Islamic Revolution, spanning over 47 years as of 2026." Removing this regime and saving the world from both conciliatory oppression and cohersion will be like a breakthrough in curing cancer.
1 · Reply
Puke_Duke
Puke_Duke Mar. 5 at 11:35 PM
$INDO $BATL $BDTX A penny for your thought's? "Iran has been a terrorist threat to the United States and Israel since the 1979 Islamic Revolution, spanning over 47 years as of 2026." Removing this regime and saving the world from both conciliatory oppression and cohersion will be like a breakthrough in curing cancer.
0 · Reply
zackopaw
zackopaw Mar. 5 at 10:00 PM
$BDTX Any news ??
1 · Reply
SpinnerInvestingTrust
SpinnerInvestingTrust Mar. 5 at 9:05 PM
$BDTX If we are down here, lets get back to 1.39 for a bit
0 · Reply
Puke_Duke
Puke_Duke Mar. 5 at 9:04 PM
$BDTX A penny for your thought's ? Typically this stock dips lower before the earnings report a day before or day of (speculated to be today, now up through March.10th 2026) Look at the projected support and resistance levels. https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=BDTX
0 · Reply
100K2022
100K2022 Mar. 5 at 8:52 PM
1 · Reply
Puke_Duke
Puke_Duke Mar. 5 at 6:12 PM
$BDTX A penny for your thought's? I was expecting their earnings report today (March 5th). The consensus is between now and (March 10th). The low today matches support from February. 15th ($2.16 +/-) THE SHORT RATIO IS (11.67) • A value of 11 days indicates materially higher covering pressure. Short sellers would need approximately 11 trading days of average volume to fully exit. This scenario often reflects: • Elevated short interest relative to liquidity. • Greater potential for upward price volatility if positive catalysts (e.g., strong clinical data, partnerships, or institutional buying) prompt covering. • Increased risk for shorts, as prolonged covering could amplify price moves in a feedback loop. • Moderate to high bearish conviction among shorts, but with added vulnerability to a short squeeze if sentiment shifts.
0 · Reply
Ramanda87
Ramanda87 Mar. 5 at 3:59 PM
$BDTX $2 avg, should have sold this trash at $5 in Nov. it’s time to rebalance my funds to another ticker. This thing is heading down for a while before it runs back up. Gd luck everyone
2 · Reply
100K2022
100K2022 Mar. 5 at 3:13 PM
$BDTX WTF?
1 · Reply
NorthStarStats
NorthStarStats Feb. 26 at 2:13 AM
For anyone following along, I developed a Python-based statistical scanner to identify stocks with near-term institutional accumulation and upward price momentum. $PRME Score:100 (again), $BDTX Score 98.00, $ABNB Score 97.00, $ALB Score 93.00, $BMEA Score 90.00
0 · Reply